Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.84B |
| 2 |
Comcast
CMCSA
|
+$1.46B |
| 3 |
Hilton Worldwide
HLT
|
+$1.38B |
| 4 |
Royal Caribbean
RCL
|
+$1.29B |
| 5 |
Canadian Natural Resources
CNQ
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.18B |
| 2 |
Intel
INTC
|
+$1.99B |
| 3 |
UnitedHealth
UNH
|
+$1.95B |
| 4 |
JPMorgan Chase
JPM
|
+$1.82B |
| 5 |
Fidelity National Information Services
FIS
|
+$1.69B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.99% |
| 2 | Technology | 17.56% |
| 3 | Communication Services | 15.03% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Hormel Foods
HRL
$13.5B
| $389M | 0.15% |
8,332,806
-5,843,804
| -41% | -$266M |
|
127
Qorvo
QRVO
$8.64B
| $386M | 0.15% |
4,792,119
-2,355,136
| -33% | -$236M |
|
128
Sarepta Therapeutics
SRPT
$1.93B
| $379M | 0.15% |
3,874,958
+1,465,905
| +61% | +$168M |
|
129
Bank of Montreal
BMO
$128B
| $378M | 0.15% |
7,483,144
+1,877,206
| +33% | +$127M |
|
130
VICI Properties
VICI
$29B
| $371M | 0.15% |
22,273,217
+4,363,744
| +24% | +$102M |
|
131
Las Vegas Sands
LVS
$29.6B
| $370M | 0.15% |
8,704,693
-13,360,711
| -61% | -$809M |
|
132
Chevron
CVX
$387B
| $369M | 0.14% |
5,095,249
-1,364,296
| -21% | -$135M |
|
|
EA
133
DELISTED
Electronic Arts
EA
| $364M | 0.14% |
3,630,076
+1,567,265
| +76% | +$165M |
|
134
Masco
MAS
$14.8B
| $359M | 0.14% |
10,379,898
-666,590
| -6% | -$29.1M |
|
135
Salesforce
CRM
$157B
| $351M | 0.14% |
2,436,617
-622,728
| -20% | -$107M |
|
136
Williams-Sonoma
WSM
$28.8B
| $351M | 0.14% |
16,500,534
+502,738
| +3% | +$16M |
|
137
Consolidated Edison
ED
$40B
| $349M | 0.14% |
+4,479,059
| New | +$393M |
|
138
Nice
NICE
$5.77B
| $346M | 0.14% |
2,407,557
+71,776
| +3% | +$11.6M |
|
139
Alexandria Real Estate Equities
ARE
$8.31B
| $343M | 0.13% |
2,499,630
+501,073
| +25% | +$78.5M |
|
140
Simon Property Group
SPG
$71.9B
| $335M | 0.13% |
6,108,783
-3,700,004
| -38% | -$442M |
|
141
Northrop Grumman
NOC
$81.6B
| $334M | 0.13% |
1,102,367
-416,988
| -27% | -$145M |
|
|
TSG
142
DELISTED
The Stars Group Inc.
TSG
| $330M | 0.13% |
16,149,773
+2,728,095
| +20% | +$61.4M |
|
|
GWPH
143
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $325M | 0.13% |
3,707,103
+84,036
| +2% | +$8.9M |
|
144
Western Union
WU
$2.26B
| $314M | 0.12% |
17,294,482
-11,675,046
| -40% | -$286M |
|
|
BLUE
145
DELISTED
bluebird bio
BLUE
| $313M | 0.12% |
525,918
+2,569
| +0.5% | +$2.5M |
|
146
Telus
TU
$15B
| $302M | 0.12% |
19,079,481
+2,709,775
| +17% | +$50.2M |
|
147
Vertex Pharmaceuticals
VRTX
$133B
| $298M | 0.12% |
1,250,664
+15
| +0% | +$3.44K |
|
148
Ultragenyx Pharmaceutical
RARE
$2.64B
| $292M | 0.11% |
6,573,960
+211,265
| +3% | +$11M |
|
149
Johnson & Johnson
JNJ
$631B
| $289M | 0.11% |
2,207,276
-691,374
| -24% | -$98.1M |
|
150
MongoDB
MDB
$36.6B
| $289M | 0.11% |
2,115,476
+23,201
| +1% | +$3.43M |
|
Similar funds
Capital Research Global Investors's Q1 2020 Portfolio in Review
As of Q1 2020, Capital Research Global Investors held 444 positions worth $255B, down 24% from $333B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Capital Research Global Investors withdrew a net $15.2B in Q1 2020, closing 47 positions and reducing 175 holdings. Its most notable exit was Skyworks Solutions, an estimated $428M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Capital Research Global Investors opened a new position in Royal Caribbean worth $455M.
- Capital Research Global Investors's largest Q1 2020 buy was Royal Caribbean: 14,133,901 shares worth $455M.
- Capital Research Global Investors added most to RTX Corp in Q1 2020, an estimated $1.84B increase.
- Capital Research Global Investors's biggest Q1 2020 reduction was AbbVie, cutting an estimated $3.18B.
- Capital Research Global Investors fully exited Skyworks Solutions in Q1 2020, selling an estimated $428M.
- Capital Research Global Investors's ten largest holdings make up 35% of its $255B portfolio in Q1 2020.
- Capital Research Global Investors opened 39 new positions and closed 47 in Q1 2020.
- Capital Research Global Investors's portfolio value fell 24% quarter-over-quarter to $255B.
Based on Capital Research Global Investors's 13F filing for Q1 2020, filed 15 May 2020.